Elite Life Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$721K Buy
617
+21
+4% +$21.5K 0.84% 18
2026
Q1
$565K Sell
596
-20
-3% -$20.3K 0.71% 20
2025
Q4
$652K Buy
616
+296
+93% +$283K 1.06% 19
2025
Q3
$265K Sell
320
-58
-15% -$43.2K 0.54% 23
2025
Q2
$295K Buy
378
+95
+34% +$73.8K 0.76% 21
2025
Q1
$234K Buy
+283
New +$235K 0.73% 23
2024
Q4
Sell
-242
Closed -$215K 28
2024
Q3
$215K Buy
242
+5
+2% +$4.5K 0.7% 26
2024
Q2
$215K Buy
+237
New +$190K 0.83% 22

Other funds holding LLY

Elite Life Management's LLY Position: Q2 2026 in Review

Elite Life Management increased its Eli Lilly (LLY) stake by 3.5% in Q2 2026, buying an estimated $21.5K and bringing the position to 617 shares worth $721K. The position accounts for 0.84% of the portfolio, ranked #18.

Elite Life Management first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Elite Life Management held 617 shares of Eli Lilly worth $721K as of Q2 2026.
  • Elite Life Management bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 0.84% of Elite Life Management's portfolio in Q2 2026, its #18 holding.
  • Elite Life Management first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Elite Life Management's 13F filing for Q2 2026, filed 6 Aug 2026.